Latest News about INVVY
Recent news which mentions INVVY
From Benzinga
From Benzinga
Nasal-Spray Millionaire: Indivior's Opvee Nasal Spray Gets FDA Green Light for Opioid Overdose Treatment
May 23, 2023
From Benzinga
Indivior Acquires Opiant Pharmaceuticals Strengthening Its Addiction Treatment And Science Portfolio
March 03, 2023
From Benzinga
Indivior Targeting Listing On NASDAQ For The Spring Of 2023
December 07, 2022
Tickers
INVVY
From Benzinga
Facebook Stalls Portal & Smartwatch Projects, Visa Breaks Debit Card Tie Up With FTX, $3B Bitcoin Withdrawn From Crypto Exchanges: Top Stories Monday, Nov. 14
November 14, 2022
From Benzinga
Indivior To Pay Over 100% Premium To Buy Opioid Focused Player Opiant Pharmaceuticals
November 14, 2022
From Benzinga
Hypocrisy All Around: Pfizer, NFL Are Hidden Sponsors Of Anti-Drug Group Fighting Against Cannabis Legalization
August 17, 2022
From Benzinga
Indivior Positioned To Profit If Aelis Farma's Study Of Cannabis Use Disorder Succeeds
June 01, 2022
Tickers
INVVY
From Benzinga
Indivior Study Shows Buprenorphine May Mitigate Fentanyl-Induced Respiratory Depression In Chronic Opioid Users
April 11, 2022
Tickers
INVVY
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|
|
|
|
|
|